The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias
Open accessAbstract
Induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM) hold promise for assessment of drug-induced arrhythmias and are being considered for use under the comprehensive in vitro proarrhythmia assay (CiPA). We studied the effects of 26 drugs and 3 drug combinations on 2 commercially available iPSC-CM types using high-throughput voltage-sensitive dye and microelectrode-array assays being studied for the CiPA initiative and compared the results with clinical QT prolongation and torsade de pointes (TdP) risk. Concentration-dependent analysis comparing iPSC-CMs to clinical trial results demonstrated good correlation between drug-induced rate-corrected action potential duration and field potential duration (APDc and FPDc) prolongation and clinical trial QTc prolongation. Of 20 drugs studied that exhibit clinical QTc prolongation, 17 caused APDc prolongation (16 in Cor.4U and 13 in iCell cardiomyocytes) and 16 caused FPDc prolongation (16 in Cor.4U and 10 in iCell cardiomyocytes). Of 14 drugs that cause TdP, arrhythmias occurred with 10 drugs. Lack of arrhythmic beating in iPSC-CMs for the four remaining drugs could be due to differences in relative levels of expression of individual ion channels. iPSC-CMs responded consistently to human ether-a-go-go potassium channel blocking drugs (APD prolongation and arrhythmias) and calcium channel blocking drugs (APD shortening and prevention of arrhythmias), with a more variable response to late sodium current blocking drugs. Current results confirm the potential of iPSC-CMs for proarrhythmia prediction under CiPA, where iPSC-CM results would serve as a check to ion channel and in silico modeling prediction of proarrhythmic risk. A multi-site validation study is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., Reinecke, H., Xu, C., Hassanipour, M., Police, S., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1327 · Cited by 2,206
REDFERN, W., CARLSSON, L., DAVIS, A., LYNCH, W., MACKENZIE, I., PALETHORPE, S., SIEGL, P., STRANG, I., SULLIVAN, A., & WALLIS, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00846-5 · Cited by 1,532
International Conference on Harmonisation
Guy, R. C. (2014) · Encyclopedia of Toxicology · doi:10.1016/b978-0-12-386454-3.00861-7 · Cited by 1,478
Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., et al. (2008) · Nature · doi:10.1038/nature06894 · Cited by 1,389 · cited 2×
“…required to differentiate human iPSCs into functional human cardiomyocytes (Burridge et al., 2012; Kattman et al., 2011; Laflamme et al., 2007; Yang et al., 2008) created the basis for the growing use of iPSC-CMs for cardiotoxicity screening of drugs (Clements and Thomas, 2014; Gibson et al.,…”
BackgroundKattman, S. J., Witty, A. D., Gagliardi, M., Dubois, N. C., Niapour, M., Hotta, A., Ellis, J., & Keller, G. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2010.12.008 · Cited by 1,159
Ma, J., Guo, L., Fiene, S. J., Anson, B. D., Thomson, J. A., Kamp, T. J., Kolaja, K. L., Swanson, B. J., & January, C. T. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00694.2011 · Cited by 770
Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties
Antzelevitch, C., Belardinelli, L., Zygmunt, A. C., Burashnikov, A., Di Diego, J. M., Fish, J. M., Cordeiro, J. M., & Thomas, G. (2004) · Circulation · doi:10.1161/01.cir.0000139333.83620.5d · Cited by 675
Burridge, P. W., Keller, G., Gold, J. D., & Wu, J. C. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2011.12.013 · Cited by 670
Sager, P. T., Gintant, G., Turner, J. R., Pettit, S., & Stockbridge, N. (2014) · American Heart Journal · doi:10.1016/j.ahj.2013.11.004 · Cited by 540
Self-citationThe Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative — Update on progress
Colatsky, T., Fermini, B., Gintant, G., Pierson, J. B., Sager, P., Sekino, Y., Strauss, D. G., & Stockbridge, N. (2016) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2016.06.002 · Cited by 464
Self-citationMICE Models: Superior to the HERG Model in Predicting Torsade de Pointes
Kramer, J., Obejero-Paz, C. A., Myatt, G., Kuryshev, Y. A., Bruening-Wright, A., Verducci, J. S., & Brown, A. M. (2013) · Scientific Reports · doi:10.1038/srep02100 · Cited by 347
Fermini, B., Hancox, J. C., Abi-Gerges, N., Bridgland-Taylor, M., Chaudhary, K. W., Colatsky, T., Correll, K., Crumb, W., Damiano, B., Erdemli, G., et al. (2016) · SLAS Discovery · doi:10.1177/1087057115594589 · Cited by 302
Self-citationNavarrete, E. G., Liang, P., Lan, F., Sanchez-Freire, V., Simmons, C., Gong, T., Sharma, A., Burridge, P. W., Patlolla, B., Lee, A. S., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000570 · Cited by 302
Crumb, W. J., Vicente, J., Johannesen, L., & Strauss, D. G. (2016) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2016.03.009 · Cited by 288
Self-citationGuo, L., Abrams, R. M. C., Babiarz, J. E., Cohen, J. D., Kameoka, S., Sanders, M. J., Chiao, E., & Kolaja, K. L. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr158 · Cited by 272
The Duration of Systole in an Electrocardiogram in Normal Humans and in Patients with Heart Disease*
Fridericia, L. S. (2003) · Annals of Noninvasive Electrocardiology · doi:10.1046/j.1542-474x.2003.08413.x · Cited by 266
Pentamidine-Induced Long QT Syndrome and Block of hERG Trafficking
Kuryshev, Y. A., Ficker, E., Wang, L., Hawryluk, P., Dennis, A. T., Wible, B. A., Brown, A. M., Kang, J., Chen, X.-L., Sawamura, K., et al. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.073692 · Cited by 258
Johannesen, L., Vicente, J., Mason, J. W., Sanabria, C., Waite-Labott, K., Hong, M., Guo, P., Lin, J., Sørensen, J. S., Galeotti, L., et al. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.155 · Cited by 254
Self-citationHarris, K., Aylott, M., Cui, Y., Louttit, J. B., McMahon, N. C., & Sridhar, A. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft113 · Cited by 227
Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias
Hoekstra, M., Mummery, C. L., Wilde, A. A. M., Bezzina, C. R., & Verkerk, A. O. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00346 · Cited by 204
Refining the Human iPSC-Cardiomyocyte Arrhythmic Risk Assessment Model
Guo, L., Coyle, L., Abrams, R. M. C., Kemper, R. A., Chiao, E. T., & Kolaja, K. L. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft205 · Cited by 185
Kim, C., Majdi, M., Xia, P., Wei, K. A., Talantova, M., Spiering, S., Nelson, B., Mercola, M., & Chen, H.-S. V. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0349 · Cited by 173
Lu, Z., Wu, C.-Y. C., Jiang, Y.-P., Ballou, L. M., Clausen, C., Cohen, I. S., & Lin, R. Z. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003623 · Cited by 172
Doherty, K. R., Wappel, R. L., Talbert, D. R., Trusk, P. B., Moran, D. M., Kramer, J. W., Brown, A. M., Shell, S. A., & Bacus, S. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.04.027 · Cited by 170
Florian, J. A., Tornøe, C. W., Brundage, R., Parekh, A., & Garnett, C. E. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010381498 · Cited by 170
Yang, T., Chun, Y. W., Stroud, D. M., Mosley, J. D., Knollmann, B. C., Hong, C., & Roden, D. M. (2014) · Circulation · doi:10.1161/circulationaha.113.007765 · Cited by 164
Stockbridge, N., Morganroth, J., Shah, R. R., & Garnett, C. E. (2013) · Drug Safety · doi:10.1007/s40264-013-0016-z · Cited by 163
Self-citationAsakura, K., Hayashi, S., Ojima, A., Taniguchi, T., Miyamoto, N., Nakamori, C., Nagasawa, C., Kitamura, T., Osada, T., Honda, Y., et al. (2015) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2015.04.002 · Cited by 153
Clements, M., & Thomas, N. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu084 · Cited by 153
Johannesen, L., Vicente, J., Mason, J. W., Erato, C., Sanabria, C. R., Waite-Labott, K., Hong, M., Lin, J., Guo, P., Mutlib, A. E., et al. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.205 · Cited by 152
Self-citationMaddah, M., Heidmann, J. D., Mandegar, M. A., Walker, C. D., Bolouki, S., Conklin, B. R., & Loewke, K. E. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.02.007 · Cited by 148
Induced Pluripotent Stem Cell–Derived Cardiomyocytes
Knollmann, B. C. (2013) · Circulation Research · doi:10.1161/circresaha.112.300567 · Cited by 132
Electrical Stimulation Promotes Cardiac Differentiation of Human Induced Pluripotent Stem Cells
Hernández, D., Millard, R. E., Sivakumaran, P., Wong, R. C. B., Crombie, D. E., Hewitt, A. W., Liang, H. H., Hung, S. S. C., Pébay, A., Shepherd, R. K., et al. (2015) · Stem Cells International · doi:10.1155/2016/1718041 · Cited by 111
Gibson, J. K., Yue, Y., Bronson, J., Palmer, C., & Numann, R. E. (2014) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2014.09.005 · Cited by 89
Talajic, M., DeRoode, M. R., & Nattel, S. (1987) · Circulation · doi:10.1161/01.cir.75.1.265 · Cited by 78
Wroblewski, H. A., Kovacs, R. J., Kingery, J. R., Overholser, B. R., & Tisdale, J. E. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06396-11 · Cited by 27
Atypical Proarrhythmia with Dofetilide: Monomorphic VT and Exercise‐Induced Torsade de Pointes
Reiffel, J. A. (2005) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2005.00179.x · Cited by 16
Lewis, K. J., Silvester, N. C., Barberini-Jammaers, S. R., Mason, S. A., Marsh, S. A., Lipka, M., & George, C. H. (2014) · SLAS DISCOVERY · doi:10.1177/1087057114557232 · Cited by 16
Nagra, B. S., Ledley, G. S., & Kantharia, B. K. (2005) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840501000307 · Cited by 14
Late dofetilide-associated life-threatening proarrhythmia
Kolb, C., Ndrepepa, G., & Zrenner, B. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.04.014 · Cited by 7
Cited by
Blinova, K., Dang, Q., Millard, D., Smith, G., Pierson, J., Guo, L., Brock, M., Lu, H. R., Kraushaar, U., Zeng, H., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.079 · Cited by 373
Self-citationInduced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development
Karagiannis, P., Takahashi, K., Saito, M., Yoshida, Y., Okita, K., Watanabe, A., Inoue, H., Yamashita, J. K., Todani, M., Nakagawa, M., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00039.2017 · Cited by 368
The evolving role of investigative toxicology in the pharmaceutical industry
Pognan, F., Beilmann, M., Boonen, H. C. M., Czich, A., Dear, G., Hewitt, P., Mow, T., Oinonen, T., Roth, A., Steger-Hartmann, T., et al. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00633-x · Cited by 255
Nguyen, N., Nguyen, W., Nguyenton, B., Ratchada, P., Page, G., Miller, P. E., Ghetti, A., & Abi-Gerges, N. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.01073 · Cited by 75
Mannhardt, I., Eder, A., Dumotier, B., Prondzynski, M., Krämer, E., Traebert, M., Söhren, K.-D., Flenner, F., Stathopoulou, K., Lemoine, M. D., et al. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx081 · Cited by 68
Metadata
- Authors
- Blinova, K., Stohlman, J., Vicente, J., Chan, D., Johannesen, L., Hortigon-Vinagre, M. P., Zamora, V., Smith, G., Crumb, W. J., Pang, L., Lyn-Cook, B., Ross, J., Brock, M., Chvatal, S., Millard, D., Galeotti, L., Stockbridge, N., & Strauss, D. G.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-10-03
- Volume
- 155
- Issue
- 1
- Pages
- 234-247
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2527750418
- Cited by
- 272
- References
- 45
- FWCI
- 21.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.